IEEE Pulse. 2021 Jul-Aug;12(4):6-10. doi: 10.1109/MPULS.2021.3094251.
Mounting evidence suggests that psychedelics may be useful for treating a range of different neuropsychiatric conditions that currently have limited treatment options. On May 4-6, 2021, leaders from academia and industry discussed a variety of issues related to the development and adoption of psychedelic drugs for different conditions during the virtual Psychedelic Therapeutics and Drug Development Conference. Selected topics from the conference are presented below.
越来越多的证据表明，迷幻药可能对治疗目前治疗选择有限的一系列不同的神经精神疾病有效。2021 年 5 月 4 日至 6 日，来自学术界和工业界的领导者在虚拟迷幻药物治疗和药物开发会议上讨论了与不同疾病的迷幻药物开发和采用相关的各种问题。现将会议的部分主题呈现如下。
